Cambridge Investment Research Advisors, Inc. - CUMBERLAND PHARMACEUTICALS I ownership

CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 29 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of CUMBERLAND PHARMACEUTICALS I
ValueSharesWeighting
Q3 2021$27,000
-3.6%
10,0000.0%0.00%
Q2 2021$28,000
-6.7%
10,0000.0%0.00%
Q1 2021$30,0000.0%10,0000.0%0.00%
Q4 2020$30,000
-6.2%
10,0000.0%0.00%
Q3 2020$32,000
-3.0%
10,0000.0%0.00%
Q2 2020$33,000
-8.3%
10,0000.0%0.00%
Q1 2020$36,000
-30.8%
10,0000.0%0.00%
Q4 2019$52,000
-11.9%
10,0000.0%0.00%
-100.0%
Q3 2019$59,000
-7.8%
10,0000.0%0.00%0.0%
Q2 2019$64,000
+10.3%
10,0000.0%0.00%0.0%
Q1 2019$58,000
-3.3%
10,0000.0%0.00%0.0%
Q4 2018$60,000
+5.3%
10,0000.0%0.00%0.0%
Q3 2018$57,000
-6.6%
10,0000.0%0.00%0.0%
Q2 2018$61,000
-9.0%
10,0000.0%0.00%0.0%
Q1 2018$67,000
-9.5%
10,0000.0%0.00%0.0%
Q4 2017$74,000
+4.2%
10,0000.0%0.00%0.0%
Q3 2017$71,000
+1.4%
10,0000.0%0.00%0.0%
Q2 2017$70,000
+1.4%
10,0000.0%0.00%0.0%
Q1 2017$69,000
+25.5%
10,0000.0%0.00%0.0%
Q4 2016$55,000
+10.0%
10,0000.0%0.00%0.0%
Q3 2016$50,000
+11.1%
10,0000.0%0.00%0.0%
Q2 2016$45,0000.0%10,0000.0%0.00%0.0%
Q1 2016$45,000
-15.1%
10,0000.0%0.00%0.0%
Q4 2015$53,000
-8.6%
10,0000.0%0.00%
-50.0%
Q3 2015$58,000
-19.4%
10,0000.0%0.00%0.0%
Q2 2015$72,000
+7.5%
10,0000.0%0.00%0.0%
Q1 2015$67,000
+11.7%
10,0000.0%0.00%0.0%
Q4 2014$60,000
+22.4%
10,0000.0%0.00%
+100.0%
Q3 2014$49,000
+8.9%
10,0000.0%0.00%
-50.0%
Q2 2014$45,00010,0000.00%
Other shareholders
CUMBERLAND PHARMACEUTICALS I shareholders Q4 2020
NameSharesValueWeighting ↓
Sterling Financial Planning, Inc. 22,031$46,0000.03%
BERKSHIRE ASSET MANAGEMENT LLC/PA 189,048$392,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 286,655$595,0000.01%
Renaissance Technologies 622,228$1,291,0000.00%
ACADIAN ASSET MANAGEMENT LLC 188,164$390,0000.00%
Oakworth Capital, Inc. 3,052$6,0000.00%
BlackRock Inc. 140,248$292,0000.00%
Citadel Advisors 32,300$67,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 28,900$60,0000.00%
TWO SIGMA ADVISERS, LP 34,592$72,0000.00%
View complete list of CUMBERLAND PHARMACEUTICALS I shareholders